Absence of OCT4 Expression in Somatic Tumor Cell Lines
The DOI matches its Crossref record.
Abstract
The POU-domain transcription factor OCT4 is associated with the pluripotent state of cells comprising the inner cell mass of pre-implantation embryos and has been known to play a critical role in the maintenance of pluripotency of embryonic stem cells. Reactivation of OCT4 expression is postulated to occur in differentiated cells that have undergone carcinogenesis, or tumor formation. In contrast to earlier studies, recent reports describe OCT4 expression in several human tumor cell lines. To resolve the apparent discrepancy in OCT4 expression between earlier and recent studies, we determined OCT4 expression in the cervical carcinoma cell line HeLa and the breast cancer cell line MCF7 in comparison with the human teratoma cell line nTera by immunofluorescence, Western blot, and RT-PCR analyses. We were unable to detect staining of the OCT4 transcription factor in the nucleus of HeLa and MCF7 cells by immunofluorescence using two different monoclonal antibodies. Faint cytoplasmic staining in HeLa and MCF7 cells was observed; however, no OCT4 signal could be detected by Western blot analysis. In addition, we were unable to detect significant levels of OCT4 mRNA in HeLa and in MCF7 cells by RT-PCR. Furthermore, the OCT4 promoter region is highly methylated in HeLa and MCF7 cells. We argue that recent reports of OCT4 expression in these and other cancer cell lines could actually be attributed to OCT4 pseudogene expression or misinterpretation of background signals in immunofluorescence experiments. In conclusion, we emphasize the need for adequate controls in investigations of OCT4 expression in somatic cell lines by immunofluorescence and RT-PCR. Disclosure of potential conflicts of interest is found at the end of this article.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Sox2 expression in breast tumours and activation in breast cancer stem cells
Leis, O., Eguiara, A., Lopez-Arribillaga, E., Alberdi, M. J., Hernandez-Garcia, S., Elorriaga, K., Pandiella, A., Rezola, R., & Martin, A. G. (2012) · Oncogene · doi:10.1038/onc.2011.338 · Cited by 514
Tsai, C.-C., Su, P.-F., Huang, Y.-F., Yew, T.-L., & Hung, S.-C. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.06.020 · Cited by 361
Functional Evidence that the Self-Renewal Gene NANOG Regulates Human Tumor Development
Jeter, C. R., Badeaux, M., Choy, G., Chandra, D., Patrawala, L., Liu, C., Calhoun-Davis, T., Zaehres, H., Daley, G. Q., & Tang, D. G. (2009) · Stem Cells · doi:10.1002/stem.29 · Cited by 335
OCT4 Spliced Variants Are Differentially Expressed in Human Pluripotent and Nonpluripotent Cells
Atlasi, Y., Mowla, S. J., Ziaee, S. A. M., Gokhale, P. J., & Andrews, P. W. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0530 · Cited by 289
Activation of the pluripotency factor OCT4 in smooth muscle cells is atheroprotective
Cherepanova, O. A., Gomez, D., Shankman, L. S., Swiatlowska, P., Williams, J., Sarmento, O. F., Alencar, G. F., Hess, D. L., Bevard, M. H., Greene, E. S., et al. (2016) · Nature Medicine · doi:10.1038/nm.4109 · Cited by 221
“…6 , this evidence is highly controversial [reviewed in Lengner et al 2 ] due to possible antibody cross-reactivity with other non-pluripotent OCT4 isoforms 7,8 , detection of OCT4 pseudogenes, low Oct4 expression levels 9,10 , and/or lack of appropriate controls (e.g., Oct4 genetic knockout cells).”
Pseudogenes: newly discovered players in human cancer.
Poliseno, L. (2012) · Science Signaling · doi:10.1126/scisignal.2002858 · Cited by 170
Ku, J.-L., Shin, Y.-K., Kim, D.-W., Kim, K.-H., Choi, J.-S., Hong, S.-H., Jeon, Y.-K., Kim, S.-H., Kim, H.-S., Park, J.-H., et al. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq043 · Cited by 52
Metadata
- Authors
- Cantz, T., Key, G., Bleidiβel, M., Gentile, L., Han, D. W., Brenne, A., & Schöler, H. R.
- Venue
- Stem Cells
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-11-21
- Volume
- 26
- Issue
- 3
- Pages
- 692-697
- ISSN
- 1066-5099 (ISSN-L)
- 1549-4918
- OpenAlex
- W2020483546
- Cited by
- 119
- References
- 0
- FWCI
- 3.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.